Stay Up to Date on CDC’s Definition of Up to Date
Key Points: COVID In today’s Recommendation for Industry, we discuss what it means to be up to date in COVID vaccinations. Read more below. CDC
Category: Communicable Disease
COVID and Monkeypox Showing Positive Trajectories
Key Points: COVID In today’s Recommendation for Industry, we discuss the positive trajectories of COVID and monkeypox. Read more below. COVID-19 may have orphaned 7.5
Be Prepared: Fall Typically Brings Increased Respiratory Disease
Key Points: COVID In today’s Recommendation for Industry, we discuss the typical increase of respiratory disease in the fall and how to prepare now. Read
The Ups and Downs of Today’s Communicable Diseases
Key Points: COVID In today’s Recommendation for Industry, we discuss the alternating status of monkeypox and Covid. Read more below. FDA authorizes updated COVID boosters
2022-23 U.S. Seasonal Influenza Vaccine Overview
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients,
Continuing Trending of Monkeypox and Covid
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Southern Hemisphere Flu Season Bodes Ill for U.S.
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19
TAG Expands Assessments to Include Current Communicable Disease Data
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings
The “Why” Behind Day 6 and Multiple COVID Testing
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for
Positive COVID Trends Enable Focus on other Emerging Disease
Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes